Jimin Health: The 'Vice President Seal Forgery Case' may cause the company a loss of approximately 30 million yuan.

① Jimin Health is preparing to respond actively, ready to make some concessions to maintain customer cooperation; ② The losses that this matter could cause are about 30 million yuan, leading to an expansion of Jimin Health's losses last year; ③ Industry experts claim that Jimin Health has leaned towards compromising with Dealers, that is, customers, and has also recognized that there are issues with its internal management.

cls.cnApr 18 08:24 ET

Has the SSE Health Care theme Index risen again? This year, the public fund performance has shuffled, with the highest return of the health care theme Fund exceeding 44%, and Inflow of capital has accelerated.

As of April 16, two SSE Health Care theme Index Funds have entered the top 10 performances of actively managed equity funds this year; Since April, multiple Hwabao WP CSI Medical Service ETFs have seen significant net subscriptions, with the total amount of fund shares for these medical ETFs reaching a new high; Fund managers believe that the pharmaceutical sector is not just undervalued in parts, but is comprehensively undervalued, and the nature of Innovative Drugs has changed.

cls.cnApr 16 20:31 ET

The humanoid robot marathon will kick off on April 19, with the industry entering a phase of intensive catalysis.

① According to reports, the world's first humanoid robot half marathon will start at 7:30 AM on April 19th in Peking Yizhuang. ② Shanghai Securities pointed out that the Siasun Robot&Automation Industry Chain has entered a stage of "a hundred flowers blooming, a hundred schools of thought contending". Currently, humanoid robots are entering industrial scenarios, which has become a highly certain application trend domestically and globally. The commercialization of humanoid robots is promising, and attention is recommended for domestic component manufacturers that will benefit.

cls.cnApr 14 19:48 ET

The price increase of Vitamins helped Xiamen Kingdomway Group achieve a 24% increase in net profit last year, while the gross profit margin of the core product coenzyme Q10 continued to be under pressure.|Interpretations

① Xiamen Kingdomway Group had a poor start but ended strong last year, meeting Brokerage expectations; ② The price increase of VA was the main reason for the performance growth, but prices have dropped to low levels this year; ③ Core product coenzyme Q10 has seen strong production and sales but the gross profit continues to decline.

cls.cnApr 9 09:36 ET

Strong policies to maintain stability inject confidence, the Agriculture chain and CSI Consumer 360 index are expected to progress together.

Track the entire lifecycle of the main Sector.

cls.cnApr 8 21:28 ET

Rare! A-share announcement of a repurchase wave: the Zhongshan system, Moutai, Midea, and GTJA have all joined in.

A-shares listed companies act with confidence, injecting stable signals into the market.

wallstreetcnApr 7 21:52 ET